BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tan YW. Risk stratification of primary liver cancer. World J Clin Cases 2022; 10(26): 9545-9549 [PMID: 36159415 DOI: 10.12998/wjcc.v10.i26.9545]
URL: https://www.wjgnet.com/2220-3249/full/v10/i26/9545.htm
Number Citing Articles
1
Haisong Hou, Liu Liang, Lihong Deng, Wanping Ye, Yuanzhang Wen, Jun Liu. Comparison of Clinical Manifestations and Related Factors of Hepatocellular Carcinoma with Chronic Hepatitis BInternational Journal of General Medicine 2024;  doi: 10.2147/IJGM.S464083
2
Hui Wang, Hao-Tian Guo, Jing Shen, Fei Zhang, Yue-Jiao Jiang, Zhen-Xing Liu. Assessment of the value of complication risk prediction models following interventional therapy for hepatocellular carcinoma in nursing decision-makingWorld Journal of Gastroenterology 2026; 32(24): 116003 doi: 10.3748/wjg.116003
3
Qiaoping Xu, Ning Ren, Lanqi Ren, Yibei Yang, Junjie Pan, Hongkai Shang. RNA m6A methylation regulators in liver cancerCancer Cell International 2024; 24(1) doi: 10.1186/s12935-023-03197-x